Riboflavin immobilized Fe3O4 magnetic nanoparticles carried with n-butylidenephthalide as targeting-based anticancer agents
n-Butylidenephthalide (BP) is a potential anti-cancer drug, which can be extracted from Angelica sinensis (Danggui). Previous reports have shown the effectiveness of BP in treating cancer diseases. However, BP has no targeting capacity towards specific cancer cells. To improve treatment efficiency a...
Main Authors: | Ching-Yi Wu, Yu-Chie Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2018.1548473 |
Similar Items
-
Butylidenephthalide Abrogates the Snail-Induced Cancer Stemness in Oral Carcinomas
by: Pei-Yin Chen, et al.
Published: (2022-05-01) -
Antitumor Effects of <i>N</i>-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells
by: Kai-Fu Chang, et al.
Published: (2020-05-01) -
The Protective Effects of n-Butylidenephthalide on Retinal Ganglion Cells during Ischemic Injury
by: Yu-Yau Chou, et al.
Published: (2022-02-01) -
N-Butylidenephthalide Inhibits the Phenotypic Switch of VSMCs through Activation of AMPK and Prevents Stenosis in an Arteriovenous Fistula Rat Model
by: Hsin-Han Yang, et al.
Published: (2020-10-01) -
Effects of riboflavin and desferrioxamine B on Fe(II) oxidation by O2
by: Peng Zhang, et al.
Published: (2022-03-01)